Skip to main content
Erschienen in: Forensic Science, Medicine and Pathology 3/2022

03.05.2022 | Case Report

A case of autopsy discovery of acute chest syndrome triggered by pulmonary embolism in a sickle cell patient

verfasst von: Kouadio Marc-Eric Victor Ebouat, Zana Konate, Zié Moussa Coulibaly, Mathurin Djodjo, Koffi Botti, Hélène Yapo-Etté

Erschienen in: Forensic Science, Medicine and Pathology | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

This is a case report about a 7-year-old male child with sickle cell anemia (S/β+) who died unexpectedly during hospitalization, justifying the performance of a forensic autopsy completed by histological examination of organ fragments and toxicological analyses of biological fluids. The diagnosis retained was pulmonary thromboembolism as the cause of death occurring in the context of an acute chest syndrome (ACS). The mechanism of occurrence of this pulmonary embolism was vascular stasis caused by sickle cell disease. The search for etiologies of ACS complicating sickle cell disease should not exclude pulmonary embolism with red cell dense fibrin clot..
Literatur
3.
Zurück zum Zitat Walker BK, Ballas SK, Burka ER. The diagnosis of pulmonary thromboembolism in sickle cell disease. Am J Hematol. 1979;7(3):219–32.CrossRef Walker BK, Ballas SK, Burka ER. The diagnosis of pulmonary thromboembolism in sickle cell disease. Am J Hematol. 1979;7(3):219–32.CrossRef
4.
Zurück zum Zitat Maître B, Mekontso-Dessap A, Habibi A, Bachir D, Parent F, Godeau B, Galacteros F. Pulmonary complications in adult sickle cell disease. Rev Mal Respir. 2011;28(2):129–37.CrossRef Maître B, Mekontso-Dessap A, Habibi A, Bachir D, Parent F, Godeau B, Galacteros F. Pulmonary complications in adult sickle cell disease. Rev Mal Respir. 2011;28(2):129–37.CrossRef
6.
Zurück zum Zitat Dessap AM, Deux JF, Abidi N, Lavenu-Bombled C, Melica G, Renaud B, et al. Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med. 2011;184(9):1022–9.CrossRef Dessap AM, Deux JF, Abidi N, Lavenu-Bombled C, Melica G, Renaud B, et al. Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med. 2011;184(9):1022–9.CrossRef
8.
Zurück zum Zitat Lakkireddy DR, Patel R, Basarakodu K, Vacek J. Fatal pulmonary artery embolism in a sickle cell patient: case report and literature review. J Thromb Thrombolysis. 2002;14(1):79–83.CrossRef Lakkireddy DR, Patel R, Basarakodu K, Vacek J. Fatal pulmonary artery embolism in a sickle cell patient: case report and literature review. J Thromb Thrombolysis. 2002;14(1):79–83.CrossRef
10.
Zurück zum Zitat Laroche JP, Durant R. Outpatient management of deep vein thrombosis in the acute phase. Sang Thromb Vaiss. 2005;17(8):470–9. Laroche JP, Durant R. Outpatient management of deep vein thrombosis in the acute phase. Sang Thromb Vaiss. 2005;17(8):470–9.
11.
Zurück zum Zitat Naik RP, Streiff MB, Lanzkron S. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know. J Thromb Thrombolysis. 2013;35(3):352–8.CrossRef Naik RP, Streiff MB, Lanzkron S. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know. J Thromb Thrombolysis. 2013;35(3):352–8.CrossRef
12.
Zurück zum Zitat Ballas SK, Lewis CN, Noone AM, Krasnow SH, Kamarulzaman E, Burka ER. Clinical, hematological, and biochemical features of Hb SC disease. Am J Hematol. 1982;13(1):37–51.CrossRef Ballas SK, Lewis CN, Noone AM, Krasnow SH, Kamarulzaman E, Burka ER. Clinical, hematological, and biochemical features of Hb SC disease. Am J Hematol. 1982;13(1):37–51.CrossRef
13.
Zurück zum Zitat Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J, Mankad VN. Causes of death in sickle cell disease: an autopsy study. Br J Haematol. 2003;123(2):359–65.CrossRef Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J, Mankad VN. Causes of death in sickle cell disease: an autopsy study. Br J Haematol. 2003;123(2):359–65.CrossRef
14.
Zurück zum Zitat Naik RP, Streiff MB, Haywood C, Nelson JA, Lanzkron S. Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication. Am J Med. 2013;126(5):443–9.CrossRef Naik RP, Streiff MB, Haywood C, Nelson JA, Lanzkron S. Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication. Am J Med. 2013;126(5):443–9.CrossRef
15.
17.
Zurück zum Zitat Cappellini MD. Coagulation in the pathophysiology of hemolytic anemias. ASH Education Program Book. 2007;2007(1):74–8. Cappellini MD. Coagulation in the pathophysiology of hemolytic anemias. ASH Education Program Book. 2007;2007(1):74–8.
18.
Zurück zum Zitat Westerman MP, Green D, Gilman-Sachs A, Beaman K, Freels S, Boggio L, Williamson P. Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med. 1999;134(4):352–62. Westerman MP, Green D, Gilman-Sachs A, Beaman K, Freels S, Boggio L, Williamson P. Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med. 1999;134(4):352–62.
19.
Zurück zum Zitat Kucuk O, Gilman-Sachs A, Beaman K, Lis LJ, Westerman MP. Antiphospholipid antibodies in sickle cell disease. Am J Hematol. 1993;42(4):380–3.CrossRef Kucuk O, Gilman-Sachs A, Beaman K, Lis LJ, Westerman MP. Antiphospholipid antibodies in sickle cell disease. Am J Hematol. 1993;42(4):380–3.CrossRef
20.
Zurück zum Zitat Ataga KI, Key NS. Hypercoagulability in sickle cell disease: new approaches to an old problem. ASH Education Program Book. 2007;2007(1):91–6. Ataga KI, Key NS. Hypercoagulability in sickle cell disease: new approaches to an old problem. ASH Education Program Book. 2007;2007(1):91–6.
21.
Zurück zum Zitat Lane PA, O’Connell JL, Marlar RA. Erythrocyte membrane vesicles and irreversibly sickled cells bind protein S. Am J Hematol. 1994;47(4):295–300.CrossRef Lane PA, O’Connell JL, Marlar RA. Erythrocyte membrane vesicles and irreversibly sickled cells bind protein S. Am J Hematol. 1994;47(4):295–300.CrossRef
22.
Zurück zum Zitat Stuart MJ, Yamaja Setty BN. Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology. Pediatr Pathol Mol Med. 2001;20(1):27–46.CrossRef Stuart MJ, Yamaja Setty BN. Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology. Pediatr Pathol Mol Med. 2001;20(1):27–46.CrossRef
23.
Zurück zum Zitat Setty BY, Kulkarni S, Rao AK, Stuart MJ. Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation. Blood. 2000;96(3):1119–24.CrossRef Setty BY, Kulkarni S, Rao AK, Stuart MJ. Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation. Blood. 2000;96(3):1119–24.CrossRef
24.
Zurück zum Zitat Styles L, DeJong K, Vichinsky E, Lubin B, Adams R, Kuypers F. Increased RBC phosphatidylserine inc exposure in sickle cell disease patients at risk for stroke by transcranial doppler screening. In Blood. Independence square west curtis center, ste 300, Philadelphia, PA 19106–3399: WB Saunders Co. 1997.90(10):2686–2686 Styles L, DeJong K, Vichinsky E, Lubin B, Adams R, Kuypers F. Increased RBC phosphatidylserine inc exposure in sickle cell disease patients at risk for stroke by transcranial doppler screening. In Blood. Independence square west curtis center, ste 300, Philadelphia, PA 19106–3399: WB Saunders Co. 1997.90(10):2686–2686
25.
Zurück zum Zitat Elalamy I. Mechanisms and risk factors of venous thrombosis. EMC Angéiologie. 2002:19–2095. Elalamy I. Mechanisms and risk factors of venous thrombosis. EMC Angéiologie. 2002:19–2095.
26.
Zurück zum Zitat Barrett-Connor E. Pneumonia and pulmonary infarction in sickle cell anemia. JAMA. 1973;224(7):997–1000.CrossRef Barrett-Connor E. Pneumonia and pulmonary infarction in sickle cell anemia. JAMA. 1973;224(7):997–1000.CrossRef
Metadaten
Titel
A case of autopsy discovery of acute chest syndrome triggered by pulmonary embolism in a sickle cell patient
verfasst von
Kouadio Marc-Eric Victor Ebouat
Zana Konate
Zié Moussa Coulibaly
Mathurin Djodjo
Koffi Botti
Hélène Yapo-Etté
Publikationsdatum
03.05.2022
Verlag
Springer US
Erschienen in
Forensic Science, Medicine and Pathology / Ausgabe 3/2022
Print ISSN: 1547-769X
Elektronische ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-022-00480-7

Weitere Artikel der Ausgabe 3/2022

Forensic Science, Medicine and Pathology 3/2022 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …